Trending

Biopharmaceutical Company, Amcure insisted on extending its team of members by further appointing  Heinz Dieter Schwer, PhD, MBA, CEO of ViraTherapeutics. Klaus Dembowsky, MD, PhD,…
Read More...

Adaptimmune Therapeutics embarks on manufacturing T-cell therapy to treat  cancer entitled SPEAR T-cells for a patient at its Navy Yard facility in Philadelphia. In addition to this…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

Ipsen declared the appointment of Richard Paulson as Executive Vice-president and Chief Executive Officer of Ipsen North America accountable for  commercial operations throughout the…
Read More...

Concert Pharmaceuticals asserted that the U.S FDA has offered Fast Track designation for CTP-543, inhibitor for treatment of moderate-to severe Alopecia Areata discerned as a serious…
Read More...

FDA approved use of Lynparza (olaparib tablets) to include treatment of patients with certain types of  Breast Cancer that have become widespread and whose tumors possess inherited…
Read More...

Gobal open-access biologics technology platform company, Wuxi Biologics declares that Dr. Chiang Syin has been appointed by Wuxi Biologics as its Chief Quality Officer accountable for…
Read More...

Boston Scientific Corporation declared optimistic outcomes from the WHISPER randomized controlled Trial.According to the data presented at the 2018 Annual meeting of the North American …
Read More...

Shiseido Company asserted that it has obtained Olivo Laboratories. Olivo is mainly a Polaris partners- based startup advancing the dermatological field through proprietary biomaterials…
Read More...

It is noteworthy that Ligand Pharmaceuticals entered into license agreement with Glenmark Pharmaceuticals to use Ligand's OmniAb platform including Omnichicken, Omnirat, OmniMouse and…
Read More...

Sarah Cannon entitled Johanna C. Bendell, MD, to Chief Development Officer. Her responsibilities encompass developing and expanding physician, site and Pharma relationships across the…
Read More...

In a bid to offer qualitative radiation therapy and cancer care services, Alliance healthcare services ventures into a stock purchasing agreement with e+CancerCare in order to function…
Read More...

LivaNova PLC commences its enrollement of patients in the Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant Study (“BELIEVE”).  A trial…
Read More...

The Medical Ethical Review Committee sought the Xcede Patch clinical trial dossier to initiate first-in-human clinical trial that eyes the treatment of up to 30 patients encountering…
Read More...

Target PharmaSolutions asserts that Novartis has entered into strategic alliance for TARGET-NASH. TARGET-NASH is a longitudinal observational study that assesses adult and pediatric…
Read More...

Adimab partners with Boehringer Ingelheim to discover and optimize antibodies against targets selected by BI who exclusively possesses the right to develop and commercialize therapeutic…
Read More...

Syndax Pharmaceuticals that is developing entinostat and SNDX-6352 in multiple cancer indications declared collaboration with a member of Roche Group, Genentech to evaluate  the…
Read More...

Pharmaceutical company ALK introduction of its sublingual allergy immunotherapy (SLIT) tablet ODACTRA set to be rolled out for US Patients in the age group of 18- 65 years afflicted…
Read More...

After the Bone, Reproductive and Urologic Drugs Advisory Committee ("BRUDAC") of the U.S. Food and Drug Administration ("FDA") voted six in favor and thirteen against the benefit/risk…
Read More...

Braeburn Pharmaceutical asserts completion of its $110- million mezzanine financing among a few others like Avista Capital Partners, RA Capital Management, New Leaf Venture Partners,…
Read More...